Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 155

1.

Airflow obstruction, lung function, and incidence of atrial fibrillation: the Atherosclerosis Risk in Communities (ARIC) study.

Li J, Agarwal SK, Alonso A, Blecker S, Chamberlain AM, London SJ, Loehr LR, McNeill AM, Poole C, Soliman EZ, Heiss G.

Circulation. 2014 Mar 4;129(9):971-80. doi: 10.1161/CIRCULATIONAHA.113.004050. Epub 2013 Dec 16.

2.

Reduced forced expiratory volume is associated with increased incidence of atrial fibrillation: the Malmo Preventive Project.

Johnson LS, Juhlin T, Engström G, Nilsson PM.

Europace. 2014 Feb;16(2):182-8. doi: 10.1093/europace/eut255. Epub 2013 Aug 19.

PMID:
23960091
3.

Socioeconomic status and the incidence of atrial fibrillation in whites and blacks: the Atherosclerosis Risk in Communities (ARIC) study.

Misialek JR, Rose KM, Everson-Rose SA, Soliman EZ, Clark CJ, Lopez FL, Alonso A.

J Am Heart Assoc. 2014 Aug 20;3(4). pii: e001159. doi: 10.1161/JAHA.114.001159.

4.

Incident atrial fibrillation among Asians, Hispanics, blacks, and whites.

Dewland TA, Olgin JE, Vittinghoff E, Marcus GM.

Circulation. 2013 Dec 3;128(23):2470-7. doi: 10.1161/CIRCULATIONAHA.113.002449. Epub 2013 Oct 8.

5.

Incidence of atrial fibrillation in whites and African-Americans: the Atherosclerosis Risk in Communities (ARIC) study.

Alonso A, Agarwal SK, Soliman EZ, Ambrose M, Chamberlain AM, Prineas RJ, Folsom AR.

Am Heart J. 2009 Jul;158(1):111-7. doi: 10.1016/j.ahj.2009.05.010.

6.

Lung function decline over 25 years of follow-up among black and white adults in the ARIC study cohort.

Mirabelli MC, Preisser JS, Loehr LR, Agarwal SK, Barr RG, Couper DJ, Hankinson JL, Hyun N, Folsom AR, London SJ.

Respir Med. 2016 Apr;113:57-64. doi: 10.1016/j.rmed.2016.02.003. Epub 2016 Feb 11.

7.

Airflow obstruction, lung function, and risk of incident heart failure: the Atherosclerosis Risk in Communities (ARIC) study.

Agarwal SK, Heiss G, Barr RG, Chang PP, Loehr LR, Chambless LE, Shahar E, Kitzman DW, Rosamond WD.

Eur J Heart Fail. 2012 Apr;14(4):414-22. doi: 10.1093/eurjhf/hfs016. Epub 2012 Feb 25.

8.

Absolute and attributable risks of atrial fibrillation in relation to optimal and borderline risk factors: the Atherosclerosis Risk in Communities (ARIC) study.

Huxley RR, Lopez FL, Folsom AR, Agarwal SK, Loehr LR, Soliman EZ, Maclehose R, Konety S, Alonso A.

Circulation. 2011 Apr 12;123(14):1501-8. doi: 10.1161/CIRCULATIONAHA.110.009035. Epub 2011 Mar 28.

9.

Echocardiographic measures of cardiac structure and function are associated with risk of atrial fibrillation in blacks: the Atherosclerosis Risk in Communities (ARIC) study.

Bekwelem W, Misialek JR, Konety S, Solomon SD, Soliman EZ, Loehr LR, Lopez FL, Fox ER, Mosley TH, Alonso A.

PLoS One. 2014 Oct 16;9(10):e110111. doi: 10.1371/journal.pone.0110111. eCollection 2014.

10.

Reduced lung function and risk of atrial fibrillation in the Copenhagen City Heart Study.

Buch P, Friberg J, Scharling H, Lange P, Prescott E.

Eur Respir J. 2003 Jun;21(6):1012-6.

11.

Association of serum uric acid with incident atrial fibrillation (from the Atherosclerosis Risk in Communities [ARIC] study).

Tamariz L, Agarwal S, Soliman EZ, Chamberlain AM, Prineas R, Folsom AR, Ambrose M, Alonso A.

Am J Cardiol. 2011 Nov 1;108(9):1272-6. doi: 10.1016/j.amjcard.2011.06.043. Epub 2011 Aug 17.

12.

Serum and dietary magnesium and incidence of atrial fibrillation in whites and in African Americans--Atherosclerosis Risk in Communities (ARIC) study.

Misialek JR, Lopez FL, Lutsey PL, Huxley RR, Peacock JM, Chen LY, Soliman EZ, Agarwal SK, Alonso A.

Circ J. 2013;77(2):323-9. Epub 2012 Oct 6.

13.

Ability of Reduced Lung Function to Predict Development of Atrial Fibrillation in Persons Aged 45 to 84 Years (from the Multi-Ethnic Study of Atherosclerosis-Lung Study).

Chahal H, Heckbert SR, Barr RG, Bluemke DA, Jain A, Habibi M, Alonso A, Kronmal R, Jacobs DR Jr, Lima JA, Watson KE, Liu K, Smith LJ, Greenland P.

Am J Cardiol. 2015 Jun 15;115(12):1700-4. doi: 10.1016/j.amjcard.2015.03.018. Epub 2015 Mar 24.

14.

Smoking and lung function in elderly men and women. The Cardiovascular Health Study.

Higgins MW, Enright PL, Kronmal RA, Schenker MB, Anton-Culver H, Lyles M.

JAMA. 1993 Jun 2;269(21):2741-8.

PMID:
8492399
15.

Occupation and three-year incidence of respiratory symptoms and lung function decline: the ARIC Study.

Mirabelli MC, London SJ, Charles LE, Pompeii LA, Wagenknecht LE.

Respir Res. 2012 Mar 20;13:24. doi: 10.1186/1465-9921-13-24.

16.

Relation between circulating CC16 concentrations, lung function, and development of chronic obstructive pulmonary disease across the lifespan: a prospective study.

Guerra S, Halonen M, Vasquez MM, Spangenberg A, Stern DA, Morgan WJ, Wright AL, Lavi I, Tarès L, Carsin AE, Dobaño C, Barreiro E, Zock JP, Martínez-Moratalla J, Urrutia I, Sunyer J, Keidel D, Imboden M, Probst-Hensch N, Hallberg J, Melén E, Wickman M, Bousquet J, Belgrave DC, Simpson A, Custovic A, Antó JM, Martinez FD.

Lancet Respir Med. 2015 Aug;3(8):613-20. doi: 10.1016/S2213-2600(15)00196-4. Epub 2015 Jul 6.

17.

Birth weight and the risk of atrial fibrillation in whites and African Americans: the Atherosclerosis Risk In Communities (ARIC) study.

Lawani SO, Demerath EW, Lopez FL, Soliman EZ, Huxley RR, Rose KM, Alonso A.

BMC Cardiovasc Disord. 2014 May 26;14:69. doi: 10.1186/1471-2261-14-69.

18.

Smoking and incidence of atrial fibrillation: results from the Atherosclerosis Risk in Communities (ARIC) study.

Chamberlain AM, Agarwal SK, Folsom AR, Duval S, Soliman EZ, Ambrose M, Eberly LE, Alonso A.

Heart Rhythm. 2011 Aug;8(8):1160-6. doi: 10.1016/j.hrthm.2011.03.038. Epub 2011 Mar 15.

19.

Race-specific impact of atrial fibrillation risk factors in blacks and whites in the southern community cohort study.

Lipworth L, Okafor H, Mumma MT, Edwards TL, Roden DM, Blot WJ, Darbar D.

Am J Cardiol. 2012 Dec 1;110(11):1637-42. doi: 10.1016/j.amjcard.2012.07.032. Epub 2012 Aug 23.

20.

Impairment of pulmonary function is an independent risk factor for atrial fibrillation: the Takahata study.

Shibata Y, Watanabe T, Osaka D, Abe S, Inoue S, Tokairin Y, Igarashi A, Yamauchi K, Kimura T, Kishi H, Aida Y, Nunomiya K, Nemoto T, Sato M, Konta T, Kawata S, Kato T, Kayama T, Kubota I.

Int J Med Sci. 2011;8(7):514-22. Epub 2011 Aug 29.

Supplemental Content

Support Center